Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Receivables (2016 - 2020)

Historic Receivables for Fresenius Medical Care AG (FMS) over the last 12 years, with Q3 2020 value amounting to $3.8 billion.

  • Fresenius Medical Care AG's Receivables rose 1924154.22% to $3.8 billion in Q3 2020 from the same period last year, while for Sep 2020 it was $3.8 billion, marking a year-over-year increase of 1924154.22%. This contributed to the annual value of $4.0 billion for FY2019, which is 292.42% up from last year.
  • As of Q3 2020, Fresenius Medical Care AG's Receivables stood at $3.8 billion, which was up 1924154.22% from -$61.1 million recorded in Q2 2020.
  • Fresenius Medical Care AG's Receivables' 5-year high stood at $4.1 billion during Q1 2020, with a 5-year trough of -$491.6 million in Q1 2019.
  • In the last 5 years, Fresenius Medical Care AG's Receivables had a median value of -$322301.4 in 2016 and averaged $936.1 million.
  • Over the last 5 years, Fresenius Medical Care AG's Receivables had its largest YoY gain of 322743059.31% in 2018, and its largest YoY loss of 432866.01% in 2018.
  • Over the past 5 years, Fresenius Medical Care AG's Receivables (Quarter) stood at -$344107.0 in 2016, then soared by 66.1% to -$116638.8 in 2017, then surged by 3227430.59% to $3.8 billion in 2018, then rose by 5.28% to $4.0 billion in 2019, then fell by 3.66% to $3.8 billion in 2020.
  • Its Receivables was $3.8 billion in Q3 2020, compared to -$61.1 million in Q2 2020 and $4.1 billion in Q1 2020.